英派药业-B(07630.HK)获纳入恒生综合指数成份股

中金财经08-24

格隆汇8月24日丨英派药业-B(07630.HK)发布公告，其已获恒生指数有限公司选定并将纳入恒生综合指数成份股，自2026年9月7日起生效。获纳入恒生综合指数成份股后，公司股份预期将符合纳入沪港通及深港通交易的标准。沪港通及深港通是香港与中国内地资本市场投资者进行股票交易及投资的渠道。　　公司认为，其获纳入恒生综合指数成份股，表明国际资本市场对公司的行业地位、经营表现及整体价值的认可。预期...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2661241386?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-24 07:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2661241386","market":"hk","top_or_hot":-1,"title":"英派药业-B(07630.HK)获纳入恒生综合指数成份股","media":"中金财经","content":"<div>\n<p>格隆汇8月24日丨英派药业-B(07630.HK)发布公告，其已获恒生指数有限公司选定并将纳入恒生综合指数成份股，自2026年9月7日起生效。获纳入恒生综合指数成份股后，公司股份预期将符合纳入沪港通及深港通交易的标准。沪港通及深港通是香港与中国内地资本市场投资者进行股票交易及投资的渠道。\n\n　　公司认为，其获纳入恒生综合指数成份股，表明国际资本市场对公司的行业地位、经营表现及整体价值的认可。预期...</p>\n\n<a href=\"http://sc.stock.cnfol.com/gushizhibo/20260824/32344064.shtml\">网页链接</a>\n\n</div>\n","source":"zhongjincaijing_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>英派药业-B(07630.HK)获纳入恒生综合指数成份股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n英派药业-B(07630.HK)获纳入恒生综合指数成份股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-24 07:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://sc.stock.cnfol.com/gushizhibo/20260824/32344064.shtml><strong>中金财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇8月24日丨英派药业-B(07630.HK)发布公告，其已获恒生指数有限公司选定并将纳入恒生综合指数成份股，自2026年9月7日起生效。获纳入恒生综合指数成份股后，公司股份预期将符合纳入沪港通及深港通交易的标准。沪港通及深港通是香港与中国内地资本市场投资者进行股票交易及投资的渠道。\n\n　　公司认为，其获纳入恒生综合指数成份股，表明国际资本市场对公司的行业地位、经营表现及整体价值的认可。预期...</p>\n\n<a href=\"http://sc.stock.cnfol.com/gushizhibo/20260824/32344064.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07630","symbol_name":"英派药业-B","start_time":0,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260824/32344064.shtml","article_id":"2661241386","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2661241386","pubTimestamp":1787529422,"columns":[],"sourceInfo":{"source_id":"zhongjincaijing_highlight","name":"中金在线"},"weMediaInfo":null,"summary":"格隆汇8月24日丨英派药业-B(07630.HK)发布公告，其已获恒生指数有限公司选定并将纳入恒生综合指数成份股，自2026年9月7日起生效。获纳入恒生综合指数成份股后，公司股份预期将符合纳入沪港通及深港通交易的标准。沪港通及深港通是香港与中国内地资本市场投资者进行股票交易及投资的渠道。\r\n\r\n　　公司认为，其获纳入恒生综合指数成份股，表明国际资本市场对公司的行业地位、经营表现及整体价值的认可。预期此举将提升股票的交易流动性，扩大并多元化股东基础，并有助于公司的长期持续增长。","collect":0,"end_time":0,"defaultTopTitle":"cnfol.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"07630":"英派药业-B","BK1161":"生物科技","HSCI":"恒生综合指数"},"translate_title":"IPP Pharmaceuticals-B (07630.HK) was included in the constituent stock of Hang Seng Composite Index","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07630":1.5,"HSCI":1.5},"content_text":"格隆汇8月24日丨英派药业-B(07630.HK)发布公告，其已获恒生指数有限公司选定并将纳入恒生综合指数成份股，自2026年9月7日起生效。获纳入恒生综合指数成份股后，公司股份预期将符合纳入沪港通及深港通交易的标准。沪港通及深港通是香港与中国内地资本市场投资者进行股票交易及投资的渠道。\n\n　　公司认为，其获纳入恒生综合指数成份股，表明国际资本市场对公司的行业地位、经营表现及整体价值的认可。预期此举将提升股票的交易流动性，扩大并多元化股东基础，并有助于公司的长期持续增长。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2661241386","isCrawlerRequest":true}